Pacific Shuanglin Bio-pharmacy Co., Ltd. (SHE:000403)

China · Delayed Price · Currency is CNY

12.90

+0.28 (2.22%)

May 29, 2026, 3:04 PM CST

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Jan '21 Jan 1, 2021	Jan '20 Jan 1, 2020	Jan '19 Jan 1, 2019	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Pharmaceutical Industry	2.63B	2.65B	2.33B	2.40B	1.97B
Pharmaceutical Industry Growth	-0.84%	14.11%	-2.93%	21.82%	88.63%
Unallocated Others	1.14M	1.05M	3.27M	9.59M	5.27M
Unallocated Others Growth	8.62%	-67.93%	-65.97%	82.15%	-29.20%
Total	2.63B	2.65B	2.33B	2.41B	1.97B
Total Growth	-0.83%	14.00%	-3.18%	21.98%	87.80%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Jan '21 Jan 1, 2021	Jan '20 Jan 1, 2020	Jan '19 Jan 1, 2019	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
China	2.63B	2.65B	2.29B	2.29B	1.95B
China Growth	-0.87%	15.70%	-0.04%	17.31%	86.10%
Foreign	4.46M	3.60M	37.43M	113.06M	17.82M
Foreign Growth	23.75%	-90.38%	-66.90%	534.38%	-
Total	2.63B	2.65B	2.33B	2.41B	1.97B
Total Growth	-0.83%	14.00%	-3.18%	21.98%	87.80%

Source: S&P Global Market Intelligence.